AUG 27, 2019 9:00 AM PDT

Akoya Biosciences Webinar Series: Comprehensive Meta-analysis of Biomarker Technologies for Predictive Response of PD-1/PD-L1 Checkpoint Therapies

Sponsored by: Akoya Biosciences
Speakers

Abstract
DATE:  August 27, 2019 
TIME:  9:00am PDT, 12:00pm EDT
 
Immunotherapies targeting the PD-1/PD-L1 interaction have proven remarkably effective for treating cancer in some patients. There has now been considerable focus into the sensitivity and specificity measures of the technologies used to predict clinical response and aid in better patient selection. Recently, researchers at Johns Hopkins School of Medicine published a comprehensive comparison in JAMA Oncology to determine the relative accuracy of these biomarker assays including PD-L1 immunohistochemistry (IHC), multiplexed immunofluoresence (mIF) and genomic approaches including tumor mutational burden (TMB) and gene expression profiling (GEP). Steve Lu, of Johns Hopkins School of Medicine will present the study results demonstrating the improved predictive value of multiplexed IHC/IF methods compared to other modalities. The review compared results of over 8000 patients from over 45 published studies detailing the treatment selection across multiple types of lung, bladder, skin, and gastric amongst other cancers. Statistical analysis of the different methods suggest multiplexed IHC/IF biomarker strategies are associated with improved predictive performance over PD-L1 IHC, TMB or GEP approaches alone.
 
Learning Objectives:
  • Comparative predictive metrics across multiple biomarker technologies for predicting PD-1/PD-L1 therapies
  • Importance of quantitative protein measurements of immune cell subsets and impact of spatial arrangements in disease states
  • Latest advances in multiplexed immunofluorescent methods for robust, high throughput clinical research.
 
 
Webinars will be available for unlimited on-demand viewing after live event.

LabRoots is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E. ® Program. By attending this webinar, you can earn 1 Continuing Education credit once you have viewed the webinar in its entirety.

Show Resources
You May Also Like
MAY 17, 2022 9:00 AM PDT
MAY 17, 2022 9:00 AM PDT
Date: May 17, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 8:00pm (CEST) Gene therapeutics have great potential to treat many severe diseases in an unprecedented, targeted manner. The biopharmace...
MAR 23, 2022 11:00 AM PDT
MAR 23, 2022 11:00 AM PDT
Date: March 23, 2021 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CEDT) In this presentation, Dr. Middleton will review the development and deployment of large-scale saliva-based COVID-19 test...
MAR 30, 2022 6:00 AM PDT
MAR 30, 2022 6:00 AM PDT
Targeted NGS has been instrumental in helping the healthcare community deliver on the promise of precision medicine. The Ion Torrent Genexus Integrated Sequencer has enabled targeted genomic...
APR 26, 2022 7:00 AM PDT
C.E. CREDITS
APR 26, 2022 7:00 AM PDT
Date: April 19, 2022 Time: 7:00am (PDT), 10:00am (EDT), 4:00pm (CEST) High-content (HC) phenotypic profiling approaches are a powerful tool to study the effect of biological, genetic, and ch...
APR 28, 2022 8:00 AM PDT
APR 28, 2022 8:00 AM PDT
Date: April 28, 2022 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Human pluripotent stem cells (PSCs) and their derivatives hold great potentials in...
DEC 09, 2021 11:00 AM PST
C.E. CREDITS
DEC 09, 2021 11:00 AM PST
Date: December 09, 2021 Time: 11:00am (PDT), 2:00pm (EDT) The burden of antimicrobial resistance (AMR) has been acknowledged worldwide by leading health institutes. Besides the need for new...
AUG 27, 2019 9:00 AM PDT

Akoya Biosciences Webinar Series: Comprehensive Meta-analysis of Biomarker Technologies for Predictive Response of PD-1/PD-L1 Checkpoint Therapies

Sponsored by: Akoya Biosciences


Show Resources
Loading Comments...
Show Resources